<DOC>
	<DOCNO>NCT01251159</DOCNO>
	<brief_summary>RATIONALE : Studying sample bone marrow patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer . PURPOSE : This laboratory study study bone marrow sample patient acute myeloid leukemia .</brief_summary>
	<brief_title>Biomarkers Bone Marrow Samples From Patients With Acute Myeloid Leukemia</brief_title>
	<detailed_description>OBJECTIVES : - To rigorously examine fractionate hematopoietic stem progenitor cell patient acute myeloid leukemia ( AML ) . - To define somatic mutation occur de novo AML , include FLT3-ITD , CEBPA , NPM1 , TET2 , ASXL1 , IDH1 , IDH2 mutation . - To examine cellular compartment ( LT-HSC , ST-HSC , CMP , GMP , MEP ) contain select mutation order mutation occur . OUTLINE : Archived bone marrow specimens analyzed sequence detection mutation Sanger-based resequencing PCR amplicons . Results compare result age-matched healthy control .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis acute myeloid leukemia Bone marrow sample must meet 1 follow criterion : Normal karyotype patient enrol ECOG1900 archive ECOG Leukemia Tissue Bank Live , sortable mononuclear cell prepared time initial diagnosis ( slowfrozen medium 10 % DMSO OR fresh cell ship immediately Agematched healthy control sample commercial provider PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>adult acute myeloid leukemia 11q23 ( MLL ) abnormality</keyword>
	<keyword>adult acute myeloid leukemia del ( 5q )</keyword>
	<keyword>adult acute myeloid leukemia inv ( 16 ) ( p13 ; q22 )</keyword>
	<keyword>adult acute myeloid leukemia ( 16 ; 16 ) ( p13 ; q22 )</keyword>
	<keyword>adult acute myeloid leukemia ( 8 ; 21 ) ( q22 ; q22 )</keyword>
	<keyword>untreated adult acute myeloid leukemia</keyword>
	<keyword>adult acute minimally differentiate myeloid leukemia ( M0 )</keyword>
	<keyword>adult acute myeloblastic leukemia maturation ( M2 )</keyword>
	<keyword>adult acute myeloblastic leukemia without maturation ( M1 )</keyword>
	<keyword>adult acute myelomonocytic leukemia ( M4 )</keyword>
	<keyword>adult acute monoblastic leukemia ( M5a )</keyword>
	<keyword>adult acute monocytic leukemia ( M5b )</keyword>
	<keyword>adult erythroleukemia ( M6a )</keyword>
	<keyword>adult pure erythroid leukemia ( M6b )</keyword>
	<keyword>adult acute megakaryoblastic leukemia ( M7 )</keyword>
</DOC>